General situation of Harbin pharmaceutical group

Harbin Pharmaceutical Group integrates pharmaceutical manufacturing, trade and scientific research, and its main business covers antibiotics, chemical pharmaceutical preparations, over-the-counter drugs and health foods.

Traditional Chinese medicine, bioengineering drugs, animal vaccines and veterinary drugs, and pharmaceutical circulation are seven major industrial fields. * * * It produces 7 series, more than 40 dosage forms and 1000 varieties of antibiotic raw materials and powder injections, Chinese patent medicines, powder injections and comprehensive preparations. The annual output of antibiotics and intermediates 13000 tons, 3 billion powder injections of western medicine, 400 million water injections, 20 billion tablets, 654.38+02.5 billion capsules, 3 billion oral liquids and 45 billion animal vaccines. All the production enterprises affiliated to Harbin Pharmaceutical Group have passed GMP certification, the main circulation enterprises have passed GSP certification, and some enterprises affiliated to Harbin Pharmaceutical General Factory and Sanjing Pharmaceutical have passed ISO 900/KOOC-0/,ISO/KOOC-0/400/KOSAS/KOOC-0/800/KOOC-0/international management system certification. Harbin Pharmaceutical Group has established more than 130 sales offices in more than 30 major urban areas in China, and has more than 200 retail chain pharmacies, forming a marketing network with wide coverage and strong functions.